Nov 10, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Patrick S. Moore and his team from University of Pittsburgh on a series of clinical proteomics projects focusing on leveraging our neoantigen quantification assays for biological discoveries.
The University of Pittsburgh (Pitt) is a public state-related research university composed of 17 undergraduate and graduate schools and colleges at its urban Pittsburgh campus. Pitt is classified as an R1 University, and was the third-largest recipient of federally sponsored health research funding among U.S. universities in 2018. According to the National Science Foundation, Pitt spent ~$1.0 billion on research and development annually, ranking it 14th in the nation.
Dr. Patrick S. Moore is an Irish and American virologist and epidemiologist who co-discovered together with his wife, Yuan Chang, two (Kaposi’s sarcoma-associated herpesvirus and Merkel cell polyomavirus) of the seven known human viruses causing cancers.